About Xinjiang Bai Hua Cun Pharma Tech Company

The company started in 1959 and was listed on the Shanghai Stock Exchange in 1996. It is mainly engaged in pharmaceutical research and development, clinical testing, testing and analysis, and commercial properties. It includes a total of 12 subsidiary companies, including Warwick Pharmaceuticals, which mainly focuses on pharmaceutical research and development, Lihua Biotech, which mainly focuses on clinical trials, Simmersberg, which focuses on analytical testing business, and commercial property management. The company's main business covers early discovery and screening of new drugs, drug CMC development, clinical trials, registration, BE/PK biological sample analysis and pharmaceutical testing services, clinical SMO and data services, MAH services, API and intermediate technology services. Corporate honors: “Market founders pay for designated markets first”; in 2004, it was rated as the 2003-2005 AAA Honest Enterprise by the Urumqi Municipal People's Government, etc.